Target intelligence / Profile preview

Ran-binding protein 3-like (RANBP3L)

Target
RANBP3L
Molecular classification
Other (nuclear transport factor), Adapter protein
01

Overview

Ran-binding protein 3-like (RANBP3L) is a protein containing a conserved Ran-binding domain and functions as a nuclear export factor specific for dephosphorylated SMAD1/5/8 in the BMP signaling pathway[1][3]. RANBP3L plays a critical role in terminating BMP signaling and regulating the differentiation of mesenchymal stem cells by mediating the nuclear export of SMADs in a Ran-dependent manner. In the kidney, RANBP3L is regulated by the transcription factor NFAT5 in response to hyperosmotic stress, supporting renal epithelial integrity and acting as a putative tumor suppressor, as its loss promotes a tumorigenic phenotype associated with renal cell carcinoma, especially the clear cell subtype[2][3]. Notes: - RANBP3L is not a typical therapeutic target (such as a receptor, enzyme, ion channel, or transporter), but a nuclear transport cofactor/adaptor. - No clinically approved drugs are known to directly interact with RANBP3L, nor are there known small-molecule modulators. - Its expression level (not function as a drug target) may be of prognostic significance in renal cancer[2]. - The gene is sometimes listed as FLJ25422 in older literature[3].

Other names
FLJ25422RNB3LRanBP3Lran-binding protein 3-like
02

Biological functions

Protein nuclear export (specifically, the nuclear export of BMP-specific SMAD1/5/8)Negative regulation of osteoblast differentiationPromotion of myogenic differentiationRegulation of mesenchymal stem cell differentiationRegulation of epithelial integrity (especially in the kidney)
03

Disease associations

Cancer (implicated as a tumor suppressor in renal cell carcinoma, particularly clear cell renal cell carcinoma)Other (roles in bone development and differentiation)
04

Biomarkers

Candidate prognostic marker for clear cell renal cell carcinoma (KIRC) [2]

Beyond the preview

Go deeper on Ran-binding protein 3-like (RANBP3L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ran-binding protein 3-like (RANBP3L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call